Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

33.92
-0.3619-1.06%
Post-market: 33.950.0327+0.10%16:10 EDT
Volume:6K
Turnover:198.03K
Market Cap:32.22M
PE:- -
High:33.97
Open:33.93
Low:33.84
Close:34.28
52wk High:36.72
52wk Low:25.59
Shares:950.00K
Float Shares:950.00K
Volume Ratio:0.88
T/O Rate:0.61%
Dividend:0.16
Dividend Rate:0.47%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Irish Central Bank Raises Growth Forecasts on AI Investment Boom

Reuters
·
1 hour ago

Steris PLC Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
3 hours ago

UnitedHealth Group Announces Earnings Release Date

THOMSON REUTERS
·
4 hours ago

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
7 hours ago

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
7 hours ago

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live
·
Yesterday

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Yesterday

Gilead announces agreement with PAHO for lenacapavir access

TIPRANKS
·
Yesterday

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS
·
Yesterday

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS
·
Yesterday

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS
·
Yesterday

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Reuters
·
Yesterday

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS
·
Yesterday

Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call

THOMSON REUTERS
·
Yesterday

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS
·
Yesterday

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Yesterday

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Yesterday

Thermo Fisher Exec Says Academic and Government Research Market Should Return to Growth in 2027 - Morgan Stanley Conference

THOMSON REUTERS
·
Yesterday

Thermo Fisher Exec Says Orders are Outpacing Revenue, Boding Well for Future Growth- Morgan Stanley Conference

THOMSON REUTERS
·
Yesterday

Dow's Nearly 300-Point Fall Led by Losses in Johnson & Johnson, Nike Stocks

Dow Jones
·
Yesterday